Device Trial Radar · NCT02761499
Post Approval Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem
Last checked: Nov 20, 2026Latest source record: Jun 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Jan 2016
Primary completion
Aug 2023
Study completion Aug 2025
Sponsor
- Lead sponsor
- United Orthopedic CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 4, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, single arm, multi-center, post-approval study designed to evaluate the short and long term clinical performance and safety in subjects receiving primary total hip arthroplasty (THA) with the U-Motion II+ Acetabular System and UTF Reduced Stem.
Conditions
- Osteoarthritis
Interventions
U-Motion II+ Acetabular SystemDevice
U-Motion II+ Acetabular System (1) U-Motion II+ acetabular cup, (2) U-Motion II+ acetabular liner, (3) Cobalt-Chrome or BIOLOX delta ceramic femoral heads, and the 4) UTF Reduced Stem
Primary outcomes
What the sponsor says the trial is designed to measure.
- Operative SuccessTime frame: 2 Years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Jacksonville Orthopaedic Institute
Jacksonville, Florida
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.